FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087983219> ?p ?o ?g. }

• W2087983219 endingPage "229" @default.
• W2087983219 startingPage "229" @default.
• W2087983219 abstract "Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity Kathleen A Ross,1 Hyelee Loyd,2 Wuwei Wu,2 Lucas Huntimer,3 Shaheen Ahmed,4 Anthony Sambol,5 Scott Broderick,6 Zachary Flickinger,2 Krishna Rajan,6 Tatiana Bronich,4 Surya Mallapragada,1 Michael J Wannemuehler,3 Susan Carpenter,2 Balaji Narasimhan1 1Chemical and Biological Engineering, Iowa State University, Ames, IA, USA; 2Animal Science, Iowa State University, Ames, IA, USA; 3Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA; 4Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA; 5Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA; 6Materials Science and Engineering, Iowa State University, Ames, IA, USA Abstract: H5N1 avian influenza is a significant global concern with the potential to become the next pandemic threat. Recombinant subunit vaccines are an attractive alternative for pandemic vaccines compared to traditional vaccine technologies. In particular, polyanhydride nanoparticles encapsulating subunit proteins have been shown to enhance humoral and cell-mediated immunity and provide protection upon lethal challenge. In this work, a recombinant H5 hemagglutinin trimer (H53) was produced and encapsulated into polyanhydride nanoparticles. The studies performed indicated that the recombinant H53 antigen was a robust immunogen. Immunizing mice with H53 encapsulated into polyanhydride nanoparticles induced high neutralizing antibody titers and enhanced CD4+ T cell recall responses in mice. Finally, the H53-based polyanhydride nanovaccine induced protective immunity against a low-pathogenic H5N1 viral challenge. Informatics analyses indicated that mice receiving the nanovaccine formulations and subsequently challenged with virus were similar to naïve mice that were not challenged. The current studies provide a basis to further exploit the advantages of polyanhydride nanovaccines in pandemic scenarios. Keywords: polymer, nanoparticle, vaccine, subunit, neutralizing antibody" @default.
• W2087983219 created "2016-06-24" @default.
• W2087983219 creator A5014996238 @default.
• W2087983219 creator A5016737623 @default.
• W2087983219 creator A5030609072 @default.
• W2087983219 creator A5035898061 @default.
• W2087983219 creator A5042843849 @default.
• W2087983219 creator A5048779111 @default.
• W2087983219 creator A5051350450 @default.
• W2087983219 creator A5054510818 @default.
• W2087983219 creator A5055380517 @default.
• W2087983219 creator A5064369983 @default.
• W2087983219 creator A5069000096 @default.
• W2087983219 creator A5074045641 @default.
• W2087983219 creator A5079203984 @default.
• W2087983219 creator A5080891568 @default.
• W2087983219 date "2014-12-01" @default.
• W2087983219 modified "2023-10-16" @default.
• W2087983219 title "Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity" @default.
• W2087983219 cites W1954030163 @default.
• W2087983219 cites W1970785335 @default.
• W2087983219 cites W1974876989 @default.
• W2087983219 cites W1977893175 @default.
• W2087983219 cites W1978340974 @default.
• W2087983219 cites W1984024271 @default.
• W2087983219 cites W1987034028 @default.
• W2087983219 cites W2017148875 @default.
• W2087983219 cites W2026161601 @default.
• W2087983219 cites W2046656605 @default.
• W2087983219 cites W2048340513 @default.
• W2087983219 cites W2054209117 @default.
• W2087983219 cites W2062784887 @default.
• W2087983219 cites W2071629929 @default.
• W2087983219 cites W2075649492 @default.
• W2087983219 cites W2078799473 @default.
• W2087983219 cites W2081182134 @default.
• W2087983219 cites W2082341895 @default.
• W2087983219 cites W2083067161 @default.
• W2087983219 cites W2088200348 @default.
• W2087983219 cites W2095521654 @default.
• W2087983219 cites W2096148942 @default.
• W2087983219 cites W2108573701 @default.
• W2087983219 cites W2131221830 @default.
• W2087983219 cites W2134599862 @default.
• W2087983219 cites W2152779030 @default.
• W2087983219 cites W2161301665 @default.
• W2087983219 cites W2163009027 @default.
• W2087983219 cites W2163960578 @default.
• W2087983219 cites W2165426348 @default.
• W2087983219 cites W2165694617 @default.
• W2087983219 cites W2170410486 @default.
• W2087983219 cites W2171059204 @default.
• W2087983219 cites W2316512281 @default.
• W2087983219 doi "https://doi.org/10.2147/ijn.s72264" @default.
• W2087983219 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4284014" @default.
• W2087983219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25565816" @default.
• W2087983219 hasPublicationYear "2014" @default.
• W2087983219 type Work @default.
• W2087983219 sameAs 2087983219 @default.
• W2087983219 citedByCount "26" @default.
• W2087983219 countsByYear W20879832192015 @default.
• W2087983219 countsByYear W20879832192016 @default.
• W2087983219 countsByYear W20879832192017 @default.
• W2087983219 countsByYear W20879832192018 @default.
• W2087983219 countsByYear W20879832192019 @default.
• W2087983219 countsByYear W20879832192020 @default.
• W2087983219 countsByYear W20879832192021 @default.
• W2087983219 countsByYear W20879832192022 @default.
• W2087983219 countsByYear W20879832192023 @default.
• W2087983219 crossrefType "journal-article" @default.
• W2087983219 hasAuthorship W2087983219A5014996238 @default.
• W2087983219 hasAuthorship W2087983219A5016737623 @default.
• W2087983219 hasAuthorship W2087983219A5030609072 @default.
• W2087983219 hasAuthorship W2087983219A5035898061 @default.
• W2087983219 hasAuthorship W2087983219A5042843849 @default.
• W2087983219 hasAuthorship W2087983219A5048779111 @default.
• W2087983219 hasAuthorship W2087983219A5051350450 @default.
• W2087983219 hasAuthorship W2087983219A5054510818 @default.
• W2087983219 hasAuthorship W2087983219A5055380517 @default.
• W2087983219 hasAuthorship W2087983219A5064369983 @default.
• W2087983219 hasAuthorship W2087983219A5069000096 @default.
• W2087983219 hasAuthorship W2087983219A5074045641 @default.
• W2087983219 hasAuthorship W2087983219A5079203984 @default.
• W2087983219 hasAuthorship W2087983219A5080891568 @default.
• W2087983219 hasBestOaLocation W20879832191 @default.
• W2087983219 hasConcept C159047783 @default.
• W2087983219 hasConcept C203014093 @default.
• W2087983219 hasConcept C2522874641 @default.
• W2087983219 hasConcept C2777546802 @default.
• W2087983219 hasConcept C2778692840 @default.
• W2087983219 hasConcept C2779341262 @default.
• W2087983219 hasConcept C2780689484 @default.
• W2087983219 hasConcept C32611913 @default.
• W2087983219 hasConcept C519248777 @default.
• W2087983219 hasConcept C86803240 @default.
• W2087983219 hasConcept C8891405 @default.
• W2087983219 hasConcept C89423630 @default.
• W2087983219 hasConceptScore W2087983219C159047783 @default.

• next